XML 41 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue from Contracts with Customers (Tables)
 6 Months Ended
Jun. 28, 2024
Disaggregation of Revenue [Line Items]  
Sales Reserves Rollforward
The following table reflects activity in the Company's sales reserve accounts:
 
Rebates and Chargebacks (1)
Product Returns Other Sales Deductions Total
Balance as of December 30, 2022 (Predecessor)$265.3 $16.0 $12.7 $294.0 
Provisions726.0 5.8 21.0 752.8 
Payments or credits(748.3)(8.6)(25.4)(782.3)
Balance as of June 30, 2023 (Predecessor)$243.0 $13.2 $8.3 $264.5 
Balance as of December 29, 2023 (Successor)$201.6 $14.5 $11.3 $227.4 
Provisions832.7 11.0 25.5 869.2 
Payments or credits(811.0)(9.6)(26.2)(846.8)
Balance as of June 28, 2024 (Successor)$223.3 $15.9 $10.6 $249.8 
(1)Includes $35.4 million and $59.0 million of accrued Medicaid and $36.8 million and $35.1 million of accrued rebates as of June 28, 2024 (Successor) and December 29, 2023 (Successor), respectively, included within accrued and other current liabilities in the unaudited condensed consolidated balance sheets.
Disaggregation of Revenue
Product sales transferred to customers at a point in time and over time were as follows:
SuccessorPredecessor
Three Months
Ended
June 28, 2024		Three Months
Ended
June 30, 2023
Product sales transferred at a point in time86.9 %83.6 %
Product sales transferred over time13.1 16.4 
SuccessorPredecessor
Six Months
Ended
June 28, 2024		Six Months
Ended
June 30, 2023
Product sales transferred at a point in time85.8 %82.0 %
Product sales transferred over time14.2 18.0 
Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment
The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of June 28, 2024 (Successor):
Remainder of Fiscal 2024$38.0 
Fiscal 202566.9 
Fiscal 202636.6 
Thereafter11.3